This is good news, now not only is FM-2030 in the excellent hands
of the folks at Alcor, but apparently he was suspended using the
recent breakthrough in protocol. Very good news indeed.
The Visionary
FM-2030
Now time traveling
Date: Tue, 11 Jul 2000 13:56:14 -0600
From: Linda Chamberlain <linda@alcor.org>
Subject: FM-2030 placed into cryostasis
News Release:
For additional information contact
Linda Chamberlain, Executive Director
linda@alcor.org
WHY BE PART OF THE LAST GENERATION TO DIE BEFORE ANTI-AGING
MEDICINE SOLVES THE AGING PROBLEM?
FOR IMMEDIATE RELEASE
Scottsdale, AZ, 11 July 2000. Futurist, lecturer and writer
FM-2030 was placed into cryostasis on July 10, 2000 at the Alcor
Life Extension Foundation in Scottsdale, Arizona.
FM-2030 was a strong advocate (for three decades) of using
cryostasis as a possible means for saving the lives of individuals
who cannot be saved by current medical technology. His books
include The Upwingers, Optimum One, Telespheres, and Are You
Transhuman?. He taught futurist classes over the
years at such locations as UCLA and the Smithsonian Institution,
and he wrote articles for major news papers like the New York Times
and the Los Angeles Times.
New surgical techniques being pioneered at Alcor were used for the
first time in the cryoprotection operation for FM-2030. These
resulted in vastly improved cryoprotection for this long-time
supporter of the cryostasis process as a potentially life saving,
though still experimental, technique.
The Alcor Life Extension Foundation was founded in 1972 as a
non-profit, tax-exempt 501(c)(3) organization, and has 39 patients
in cryostasis. Alcor is the world's largest provider of
professional cryotransport services with over 500 members who have
pre-arranged for cryotransport. Alcor's Emergency CryoTransport
System (ECS) is a medical-style rescue network patterned after
Emergency Medical System (EMS). Alcor CryoTransport Technicians,
as with EMS technicians, are remotely advised by on-call physicians
who are Alcor members and/or contract physicians.
If an individual is successfully placed into cryostasis, there are
patient funds for long term care. These funds are maintained in an
independent Patient Care Trust and are invested such that they have
traditionally earned at least double the current costs of keeping
patients in cryostasis, providing extra safety margin against poor
investment years.
Can patients in cryostasis be successfully resuscitated, perhaps
decades from now, when new medical breakthroughs can reverse the
damage caused by diseases not currently curable? The medical and
scientific foundations for this are discussed at length in a new
book: Nanomedicine, Volume I, by Robert Freitas. These
revolutionary concepts were presented by Ralph Merkle, PhD at the
Fourth Alcor Conference on Life Extension Technologies held in June
2000.
For more information on the Alcor Life Extension Foundation, see
our website at <http://www.alcor.org/>www.alcor.org
###
This archive was generated by hypermail 2b29 : Mon Oct 02 2000 - 17:34:25 MDT